French medical diagnostics outfit Labco is inching closer to an IPO, filing plans to go public during the first half of 2015 to generate growth and expand its footprint in the field.
Researchers at the University of Illinois-Chicago have developed a nanoparticle-based robot that can detect humidity thanks to the use of bacterial spores and a form of carbon known as graphene.
Health Diagnostic Laboratory has reportedly reached a $47 million settlement with the Department of Justice. HDL will deny wrongdoing and enter into a corporate integrity agreement with the Department of Health and Human Services.
The enactment of the Affordable Care Act with its expansion of Medicaid benefits has led to an uptick in diabetes diagnoses by almost one-quarter, according to a study of deidentified test results from Quest Diagnostics. That's in states that opted to expand Medicaid under the new law during the first 6 months of 2014 as compared to the first 6 months of 2013.
Last June, Auxogyn's Eeva System was the first to be cleared by FDA to aid in IVF embryo selection in combination with traditional morphology. Now the startup has raised $34.3 million, out of a planned $41 million, financing round to start commercializing this test, according to an SEC filing.
Canon U.S.A. just announced its BioMedical subsidiary earlier this month. Now it's made its first med tech deal, an investment in Canadian diagnostic startup Spartan Bioscience, offering a glimpse of what to expect in the future from this new direction for the digital imaging company.
23andMe has brought in the former EVP of research and early development from Genentech, Richard Scheller, as CSO and head of a newly created therapeutics group. The move seems likely to be a precursor to a major cash infusion.
Sequenom has long depended on its noninvasive prenatal diagnostic test to drive growth and fuel expansion. But now, the company unveiled new results which show that its MaterniT21 test can detect signs of cancer in pregnant women, a potential game-changer as Sequenom looks to expand its market reach.
It's one of those ideas that sounds wacky and way out there, but researchers at the University of California, San Diego, have apparently found a way to draw a blood glucose sensor onto a patient's skin using regular ballpoint pen.
As the med tech industry homes in on innovative technologies that can speed up diagnosis for strokes, healthcare providers are harnessing next-generation products to improve outcomes for patients.